PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IAK vs. IHE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


IAKIHE
YTD Return32.56%14.81%
1Y Return40.55%25.78%
3Y Return (Ann)18.27%4.56%
5Y Return (Ann)15.36%9.50%
10Y Return (Ann)12.51%5.30%
Sharpe Ratio2.801.77
Sortino Ratio3.662.49
Omega Ratio1.501.31
Calmar Ratio6.071.61
Martin Ratio17.746.53
Ulcer Index2.29%3.34%
Daily Std Dev14.50%12.32%
Max Drawdown-77.38%-38.20%
Current Drawdown-1.60%-3.45%

Correlation

-0.50.00.51.00.6

The correlation between IAK and IHE is 0.56, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

IAK vs. IHE - Performance Comparison

In the year-to-date period, IAK achieves a 32.56% return, which is significantly higher than IHE's 14.81% return. Over the past 10 years, IAK has outperformed IHE with an annualized return of 12.51%, while IHE has yielded a comparatively lower 5.30% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-5.00%0.00%5.00%10.00%15.00%JuneJulyAugustSeptemberOctoberNovember
13.55%
8.35%
IAK
IHE

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


IAK vs. IHE - Expense Ratio Comparison

IAK has a 0.43% expense ratio, which is higher than IHE's 0.42% expense ratio.


IAK
iShares U.S. Insurance ETF
Expense ratio chart for IAK: current value at 0.43% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.43%
Expense ratio chart for IHE: current value at 0.42% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.42%

Risk-Adjusted Performance

IAK vs. IHE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Insurance ETF (IAK) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IAK
Sharpe ratio
The chart of Sharpe ratio for IAK, currently valued at 2.80, compared to the broader market-2.000.002.004.006.002.80
Sortino ratio
The chart of Sortino ratio for IAK, currently valued at 3.66, compared to the broader market-2.000.002.004.006.008.0010.0012.003.66
Omega ratio
The chart of Omega ratio for IAK, currently valued at 1.50, compared to the broader market1.001.502.002.503.001.50
Calmar ratio
The chart of Calmar ratio for IAK, currently valued at 6.07, compared to the broader market0.005.0010.0015.006.07
Martin ratio
The chart of Martin ratio for IAK, currently valued at 17.74, compared to the broader market0.0020.0040.0060.0080.00100.0017.74
IHE
Sharpe ratio
The chart of Sharpe ratio for IHE, currently valued at 1.77, compared to the broader market-2.000.002.004.006.001.77
Sortino ratio
The chart of Sortino ratio for IHE, currently valued at 2.49, compared to the broader market-2.000.002.004.006.008.0010.0012.002.49
Omega ratio
The chart of Omega ratio for IHE, currently valued at 1.31, compared to the broader market1.001.502.002.503.001.31
Calmar ratio
The chart of Calmar ratio for IHE, currently valued at 1.61, compared to the broader market0.005.0010.0015.001.61
Martin ratio
The chart of Martin ratio for IHE, currently valued at 6.53, compared to the broader market0.0020.0040.0060.0080.00100.006.53

IAK vs. IHE - Sharpe Ratio Comparison

The current IAK Sharpe Ratio is 2.80, which is higher than the IHE Sharpe Ratio of 1.77. The chart below compares the historical Sharpe Ratios of IAK and IHE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.001.502.002.503.00JuneJulyAugustSeptemberOctoberNovember
2.80
1.77
IAK
IHE

Dividends

IAK vs. IHE - Dividend Comparison

IAK's dividend yield for the trailing twelve months is around 1.21%, less than IHE's 1.52% yield.


TTM20232022202120202019201820172016201520142013
IAK
iShares U.S. Insurance ETF
1.21%1.44%1.69%2.26%2.07%1.84%2.33%1.62%1.68%1.62%1.57%1.14%
IHE
iShares U.S. Pharmaceuticals ETF
1.52%1.39%2.01%1.49%1.19%1.40%1.25%1.36%0.92%1.93%1.20%1.06%

Drawdowns

IAK vs. IHE - Drawdown Comparison

The maximum IAK drawdown since its inception was -77.38%, which is greater than IHE's maximum drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for IAK and IHE. For additional features, visit the drawdowns tool.


-7.00%-6.00%-5.00%-4.00%-3.00%-2.00%-1.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-1.60%
-3.45%
IAK
IHE

Volatility

IAK vs. IHE - Volatility Comparison

iShares U.S. Insurance ETF (IAK) has a higher volatility of 6.14% compared to iShares U.S. Pharmaceuticals ETF (IHE) at 3.68%. This indicates that IAK's price experiences larger fluctuations and is considered to be riskier than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%JuneJulyAugustSeptemberOctoberNovember
6.14%
3.68%
IAK
IHE